Neuroprotective Effects of Diazepam, Carbamazepine, Phenytoin and Ketamine after Pilocarpine-induced Status Epilepticus


Autoria(s): CUNHA, Alexandra Olimpio Siqueira; MORTARI, Marcia Renata; LIBERATO, Jose Luiz; SANTOS, Wagner Ferreira dos
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2009

Resumo

Cell damage and spatial localization deficits are often reported as long-term consequences of pilocarpine-induced status epilepticus. In this study, we investigated the neuroprotective effects of repeated drug administration after long-lasting status epilepticus. Groups of six to eight Wistar rats received microinjections of pilocarpine (2.4 mg/mu l, 1 mu l) in the right dorsal hippocampus to induce a status epilepticus, which was attenuated by thiopental injection (35 mg/kg, i.p.) 3 hrs after onset. Treatments consisted of i.p. administration of diazepam, ketamine, carbamazepine, or phenytoin at 4, 28, 52, and 76 hr after the onset of status epilepticus. Two days after the treatments, rats were tested in the Morris water maze and 1 week after the cognitive tests, their brains were submitted to histology to perform haematoxylin and eosin staining and glial fibrillary acidic protein (GFAP) immunofluorescence detection. Post-status epilepticus rats exhibited extensive gliosis and cell loss in the hippocampal CA1, CA3 (70% cell loss for both areas) and dentate gyrus (60%). Administration of all drugs reduced cell loss in the hippocampus, with best effects observed in brains slices of diazepam-treated animals, which showed less than 30% of loss in the three areas and decreased GFAP immunolabelling. Treatments improved spatial navigation during training trials and probe trial, with exception of ketamine. Interestingly, in the probe trial, only diazepam-treated animals showed preference for the goal quadrant. Our data point to significant neuroprotective effects of repeated administration of diazepam against status epilepticus-induced cell damage and cognitive disturbances.

Brazilian National Research Council (CNPq)

Brazilian Council for Research (Capes)

Sao Paulo State Research Foundation (FAPESP)

Identificador

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, v.104, n.6, p.470-477, 2009

1742-7835

http://producao.usp.br/handle/BDPI/20677

10.1111/j.1742-7843.2009.00403.x

http://dx.doi.org/10.1111/j.1742-7843.2009.00403.x

Idioma(s)

eng

Publicador

WILEY-BLACKWELL PUBLISHING, INC

Relação

Basic & Clinical Pharmacology & Toxicology

Direitos

restrictedAccess

Copyright WILEY-BLACKWELL PUBLISHING, INC

Palavras-Chave #TEMPORAL-LOBE EPILEPSY #SPONTANEOUS RECURRENT SEIZURES #HIPPOCAMPAL SCLEROSIS #SILENT PERIOD #BRAIN-DAMAGE #MODEL #RATS #EPILEPTOGENESIS #TOPIRAMATE #NEURONS #Pharmacology & Pharmacy #Toxicology
Tipo

article

original article

publishedVersion